Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New Switch: Peginterferon alfa-2a Switch in CHB
NCT01464281Phase 4Unknown
- Sponsor
- The 2nd Affiliated Hospital of Chongqing Medical University
- Start
- Oct 2011
- Primary completion
- Jun 2016
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Status: unknown.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01464281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01464281.